InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,463.54
(
0.08%
)
US TECH 100
18,578.40
(
0.12%
)
Dow Jones
40,539.93
(
-0.12%
)
Brent Oil
78.98
(
-0.21%
)
Bitcoin
66,506.48
(
-0.48%
)
Post# of 252727
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

semi_infinite

Send PM Follow Ignore
Followers 14
Posts 3823
Boards Moderated 1
Alias Born 07/07/2002

semi_infinite

Re: semi_infinite post# 216068

Monday, 12/18/2017 10:04:28 AM

Monday, December 18, 2017 10:04:28 AM

Post# of 252727
TRXC - sells rights to develop and market Surgibot to Chinese. Surgibot is a single port system that was previously rejected by the FDA via 510K route. It probably has to go through PMA route if they try again to get clearance costing much money and time. Good to focus their efforts on the approved platform and going "scarless" via 2.7 mm instruments while clinical data gets gathered in China.

http://ir.transenterix.com/releasedetail.cfm?ReleaseID=1052008
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up